The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement

Conditions:   Aortic Valve Stenosis;   Heart Failure;   Inotropic Agents;   Safety Issues;   Effect of Drug;   Cardiac Event;   Transcatheter Aortic Valve Replacement Interventions:   Drug: Levosimendan;   Other: Placebo Sponsors:   China National Center for Cardiovascular Diseases;   China International Medical Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials